PET / CT
A PET/CT scan combines positron emission tomography (PET) images with computed tomography (CT) images to help doctors identify disorders or diseases, such as cancer, deep inside the body.
CT scans provide anatomical images, and PET scans measure disease processes. A CT scan may identify a suspected tumor, while a PET scan may help determine if a tumor is malignant or has spread. Combining both technologies provides convenience for patients and greater accuracy for physicians in diagnosing, staging, and treating disease.
Patients who have a PET/CT scan usually receive a radioactive glucose tracer called F-18 fluorodeoxyglucose, or FDG, in an IV infusion. A PET scan can identify the presence of cancer cells because they metabolize glucose faster than normal cells. A contrast dye may also be administered to provide as much detail as possible in the CT images.
Mobile Molecular Imaging uses the GE Discovery ST, a highly advanced PET/CT scanner designed to enhance patient comfort and provide superior image quality.